Literature DB >> 21845422

[Photodynamic diagnostics of bladder carcinoma].

F Vom Dorp1, S Tschirdewahn, T Olbricht, T Szarvas, H Rübben.   

Abstract

The question whether conventional cystoscopy should always be performed together with fluorescent diagnostic procedures remains to be answered. The current article presents the current literature dealing with this topic. Particularly for relevant carcinoma in situ lesions of the bladder there is no obvious advantage for photodynamic diagnostics compared to conventional cystoscopy with consistent use of urine cytology.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21845422     DOI： 10.1007/s00120-011-2696-2

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  13 in total

1.  Watchful waiting policy in recurrent Ta G1 bladder tumors.

Authors:  Ofer N Gofrit; Dov Pode; Adi Lazar; Ran Katz; Amos Shapiro
Journal:  Eur Urol       Date:  2006-01-06       Impact factor: 20.096

2.  Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.

Authors:  Arnulf Stenzl; Hannes Penkoff; Elfriede Dajc-Sommerer; Andreas Zumbraegel; Lorenz Hoeltl; Michael Scholz; Claus Riedl; Josef Bugelnig; Alfred Hobisch; Maximilian Burger; Gregor Mikuz; Uwe Pichlmeier
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.

Authors:  Arnulf Stenzl; Maximilian Burger; Yves Fradet; Lance A Mynderse; Mark S Soloway; J Alfred Witjes; Martin Kriegmair; Alexander Karl; Yu Shen; H Barton Grossman
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

4.  [Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].

Authors:  J Hess; S Tschirdewahn; T Szarvas; R Rossi; H Rübben; F Vom Dorp
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

5.  Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?

Authors:  H W Herr
Journal:  BJU Int       Date:  2001-11       Impact factor: 5.588

6.  A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.

Authors:  Yves Fradet; H Barton Grossman; Leonard Gomella; Seth Lerner; Michael Cookson; David Albala; Michael J Droller
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

7.  A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.

Authors:  H Barton Grossman; Leonard Gomella; Yves Fradet; Alvaro Morales; Joseph Presti; Chad Ritenour; Unyime Nseyo; Michael J Droller
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

8.  Expectant management of small, recurrent, noninvasive papillary bladder tumors.

Authors:  Mark S Soloway; Darren S Bruck; Sandy S Kim
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

9.  Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.

Authors:  Martin C Schumacher; Sten Holmäng; Thomas Davidsson; Bengt Friedrich; Jörgen Pedersen; N Peter Wiklund
Journal:  Eur Urol       Date:  2009-11-06       Impact factor: 20.096

10.  [Urine-based cytological diagnosis against the background of the new histopathological classification].

Authors:  S Tschirdewahn; C Boergermann; M Becker; T Szarvas; H Rübben; F vom Dorp
Journal:  Urologe A       Date:  2009-06       Impact factor: 0.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.